Loading stock data…
$0.25-0.01 (-2.77%)
KALA BIO, Inc., a biopharmaceutical company, engages in the development of an on-premises artificial intelligence (AI) infrastructure platform for biotechnology research applications in the United States.
KALA BIO, Inc. in the Healthcare sector is trading at $0.25 with a market capitalization of $10M. The stock is currently near its 52-week low of $0.25, remaining 97.1% below its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: RSI 12 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 25/100 signals elevated caution as multiple indicators diverge.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$1.72M↑ | -$1.80M↑ | -$10.22M↓ | -$10.18M↑ | -$10.33M |
| Net Income | -$1.58M↑ | -$1.62M↓ | $686,000↑ | -$7.56M↑ | -$11.15M |
KALA BIO, Inc., a biopharmaceutical company, engages in the development of an on-premises artificial intelligence (AI) infrastructure platform for biotechnology research applications in the United States. The company develops Researgency, an agentic ...